Technology ID
TAB-4886

Elucidation of CD300 Family Proteins' Roles in Immune Response: A Study Utilizing Transduced L929 Cells and Genetically Modified Murine Models

E-Numbers
E-072-2018-0
Lead Inventor
Coligan, John
Lead IC
NIAID
Co-Inventors
Krzewski, Konrad
Voss, Oliver
Lee, Ha Na
Tian, Linjie
ICs
NIAID
Applications
Diagnostics
Therapeutic Areas
Immunology
Development Stages
Pre-Clinical (in vitro)
Research Products
Research Equipment
Antibodies
Animal Models

In this research endeavor, a multifaceted approach has been employed to investigate the intricate roles of CD300 family proteins in immunological processes. Lentiviral transduction of the L929 cell line with mouse and human CD300f genes, followed by puromycin selection, has established cellular models to examine the functions of these receptors. Concurrently, engineered constructs encoding extracellular domains of mouse CD300lb and CD300ld, fused with human IgG1, have been developed for the production of receptor extracellular domain proteins, facilitating studies on protein interactions. Additionally, genetically modified murine models, including CD300f-deficient mice created on a C57BL/6 background and CD300a-deficient mice obtained as embryos and cross-bred, enable the exploration of the biological functions of these genes in vivo. This comprehensive approach allows for a thorough investigation into the immunological significance of CD300 family proteins across various experimental contexts.

 

Commercial Applications
The results of this research offer potential applications in immunotherapy development, diagnostics, and a deeper understanding of immune system regulation. The engineered protein constructs can be used in antibody-based assays for detecting protein interactions. Additionally, insights from the genetically engineered murine models may have broader implications for immune-related diseases and basic immunological research. This research has the potential to advance both fundamental immunology and practical applications in medicine and diagnostics.

Competitive Advantages
This research's competitive edge lies in its holistic approach to studying CD300 family proteins in immunological processes. By transducing both mouse and human CD300f genes into L929 cells and employing rigorous selection, we enable comparative analysis for species-specific insights. Engineered protein constructs facilitate in vitro investigations into protein interactions. The inclusion of genetically engineered murine models offers valuable in vivo context for studying CD300 gene functions. This comprehensive strategy positions our research at the forefront of understanding CD300 family proteins in immunology.
Licensing Contact:
Taylor-Mulneix, Dawn
dawn.taylor-mulneix@nih.gov